Combination of apatinib mesylate and second-line chemotherapy for treating gastroesophageal junction adenocarcinoma

OBJECTIVE: To investigate the safety and efficacy of acitinib mesylate combined with chemotherapy in the treatment of patients with gastroesophageal junction adenocarcinoma. METHODS: A total of 119 patients with gastroesophageal junction adenocarcinoma were enrolled and randomized into an experiment...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Int Med Res
Hlavní autoři: Lu, Bin, Lu, Chaoyun, Sun, Zheng, Qu, Caiping, Chen, Ji, Hua, Zhaolai, Tong, Ruimin, Zhang, Junfeng
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2019
Témata:
Pre-Clinical Research Reports
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6567765/
https://ncbi.nlm.nih.gov/pubmed/30991863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060519827191
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky